NFA
NVCR icon

Nationwide Fund Advisors’s NovoCure NVCR Stock Holding History

Nationwide Fund Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-32,094
Closed -$637K – 1405
2017
Q3 		$637K Sell
32,094
-623
-2% -$12.2K ﹤0.01% 2056
2017
Q2 		$566K Buy
32,717
+3,436
+12% +$44.4K ﹤0.01% 2116
2017
Q1 		$237K Sell
29,281
-43,495
-60% -$314K ﹤0.01% 2510
2016
Q4 		$571K Sell
72,776
-680
-0.9% -$5.47K ﹤0.01% 2112
2016
Q3 		$627K Sell
73,456
-1,565
-2% -$14.3K ﹤0.01% 2061
2016
Q2 		$875K Buy
75,021
+70,121
+1,431% +$878K ﹤0.01% 1813
2016
Q1 		$71K Sell
4,900
-10
-0.2% -$143 ﹤0.01% 2919
2015
Q4 		$110K Buy
+4,910
New +$117K ﹤0.01% 2806

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Nationwide Fund Advisors's NVCR Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of NovoCure (NVCR) in Q4 2017, closing a stake of 32,094 shares — an estimated $637K sold.

Nationwide Fund Advisors first reported a position in NVCR in Q4 2015 and held it in 8 quarters. The position peaked at $875K in Q2 2016. 128 funds tracked by Wall St. Rank hold NVCR as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining NovoCure position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 32,094 NovoCure shares in Q4 2017, an estimated $637K.
  • Nationwide Fund Advisors first reported a position in NovoCure in Q4 2015 and held it in 8 quarters.
  • Nationwide Fund Advisors's NovoCure position peaked at $875K in Q2 2016.
  • 128 funds tracked by Wall St. Rank held NovoCure as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.